Is 7mm breast cancer considered early stage?

7mm breast cancer is usually in the early stage, and the treatment is mainly surgical resection, combined with radiotherapy, chemotherapy or targeted therapy, with a good prognosis. The early diagnosis of breast cancer is closely related to the size of the tumor and lymph node metastasis. The 7mm tumor is small in size, and when there is no distant metastasis, early intervention can significantly improve the survival rate.

1. The staging of breast cancer is mainly based on the size of the tumor, the involvement of lymph nodes, and the presence of distant metastasis. A 7 mm tumor is usually classified as T1a, which is early breast cancer. Early breast cancer tumors are small in size and do not invade surrounding tissues or lymph nodes. The treatment effect is better, and the five-year survival rate can reach more than 90%.

2. The treatment of early breast cancer is mainly surgical. Common surgical methods include breast-conserving surgery and mastectomy. Breast-conserving surgery is suitable for patients with small tumors in suitable locations. Radiotherapy is required after surgery to reduce the risk of recurrence. Mastectomy is suitable for patients with large tumors or multifocal lesions. After surgery, adjuvant therapy can be decided based on pathological results.

3. Adjuvant therapy includes chemotherapy, radiotherapy and targeted therapy. Chemotherapy is suitable for high-risk patients, and commonly used drugs include cyclophosphamide, doxorubicin and paclitaxel. Radiotherapy is mainly used after breast-conserving surgery to reduce local recurrence. Targeted therapy is suitable for HER2-positive patients, and commonly used drugs include trastuzumab and pertuzumab.

4. The prognosis of early breast cancer is related to multiple factors, including tumor grade, hormone receptor status, and patient age. Hormone receptor-positive patients can receive endocrine therapy, such as tamoxifen or aromatase inhibitors, to reduce the risk of recurrence. Young patients need to pay attention to the protection of reproductive function, and ovarian function suppression therapy can be considered if necessary.

5. Regular follow-up is an important part of early breast cancer management, including breast ultrasound, mammography and tumor marker testing. The frequency of follow-up depends on the specific situation of the patient, usually once every 3-6 months, and can be changed to once a year after 5 years. During the follow-up period, attention should be paid to the patient's mental state and psychological support should be provided when necessary.

7mm breast cancer is considered early stage. Through standardized surgery and adjuvant therapy, patients can obtain good prognosis. Early diagnosis and comprehensive treatment are the key to improving survival rate. Patients should actively cooperate with doctors to develop personalized treatment plans and adhere to regular follow-up to reduce the risk of recurrence and improve the quality of life.